entertainment -WSS

entertainment

author：fashion 2025-09-27 09:40:27 - browse：2

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Study: AI not yet building 'n

explore

WSS

Inside the rise of 'mukbang' eating videos

Brain worms: The science behind RFK Jr.'s parasitic infection

How to fix the rural physician shortage in the U.S.

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Study: Adult vaccinations pay for themselves in societal benefits

Steward Health Care files for bankruptcy

entertainment

entertainment

leisure time

What does generative AI mean for health care? We asked experts

Sanofi strikes deal with Novavax, boosting the vaccine maker

As demand for Covid shots wanes, Moderna seeks its next success

The thinking behind the controversial eating disorder chatbot Tessa

Cancer drug shortages should be causing more outrage

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Moonlake's readout produced a cash windfall. Risks remain

Medicare says breakthrough device reimbursement rule to come by summer

Jerome Adams on the need for new antivirals for Covid

CDC wastewater surveillance dashboard to track bird flu hotspots

leisure time

Senate panel passes drug pricing bills, but drops one PBM reform

How to improve immunocompromised access to mAb treatments

Study: Adult vaccinations pay for themselves in societal benefits

Mom launches Girl Scout troop for LGBTQ youth in Texas

Researchers on aging grapple with how to calculate biological age

Dairy farmers resist CDC push for PPE against bird flu virus

hotspot

hotspot

explore

explore